VentriPoint Diagnostics

VentriPoint Diagnostics EBIT per Employee

EBIT per Employee of VentriPoint Diagnostics (VPT.V) as of Oct 17, 2026.

EBIT per Employee

-CAD

Last updated:

EBIT per Employee of VentriPoint Diagnostics is 2026 - CAD. EBIT per Employee of VentriPoint Diagnostics was 2025 - CAD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

VentriPoint Diagnostics Stock analysis

What does VentriPoint Diagnostics do? VentriPoint Diagnostics Ltd., headquartered in Toronto, Canada, operates in the Health Care sector, specializing in diagnostic tools for heart disease monitoring. The company develops the VentriPoint Medical System (VMS+), a point-of-care solution that uses 3D ultrasound technology to visualize heart structure and function without MRI, leveraging proprietary Knowledge Based Reconstruction (KBR) for accurate volume and ejection fraction calculations. Its applications cover congenital heart disease, pulmonary hypertension, pregnancy, and oncology-related cardiotoxicity. Listed on 9 November 2005, VentriPoint focuses on innovative cardiac diagnostics. VentriPoint Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about VentriPoint Diagnostics stock

On Eulerpool you can find the complete historical development of EBIT per Employee VentriPoint Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's VentriPoint Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — VentriPoint Diagnostics

All Key Metrics — VentriPoint Diagnostics